Skip to main content
Login
Contact
Subscribe
Search form
Search
The Decatur Daily Democrat
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Biotechnology Index NYSE ETF
(NY:
FBT
)
162.43
USD
-0.03 (-0.02%)
Official Closing Price
Updated: 7:59 PM EDT, Apr 16, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Biotechnology Index NYSE ETF
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
24
25
Next >
Taking the Technical Temperature of Biotech ETFs
October 21, 2016
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, and rival biotechnology exchange traded funds have been hampered by presidential politics this year....
Tags
XBI
BIS
Biotechnology
From
ETF Trends
Exclusive: SunTrust Managing Director Shares Thoughts On Drug Pricing, Impact On Biotech
October 20, 2016
Drug pricing has been one of the hot topics of the year. As Citron Research's controversial executive editor Andrew Left said last ...
Tags
Benzinga
Health Care
Andrew Left
From
Benzinga
Investors Grab NKTR Even Cheaper Than Its Secondary Stock Offering
October 20, 2016
Looking back to 2 days ago, Nektar Therapeutics (NKTR) priced a 13,000,000 share secondary stock offering at $13.50 per share. Buyers in that offering made a considerable investment into the company,...
Tags
Stocks
From
Market News Video
Acadia Pharmaceuticals Enters Oversold Territory (ACAD)
October 05, 2016
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
The Way to Profit From the Biotech Story No One Is Talking About
September 16, 2016
By the standard of today’s mega-mergers, a $4 million investment seems like pretty small change.
Tags
ETF's
Healthcare
Stocks / Equities
From
Blogs - TalkMarkets
Analysts Anticipate FBT Will Reach $119
September 16, 2016
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Candidate Clinton's Proposal To Combat Drug Price Hikes
September 02, 2016
Hillary Clinton, Democratic presidential nominee, introduced a new plan to address the "unjustified" price increases on life-savings ...
Tags
SPY
Reuters
Health Care
From
Benzinga
Top Buys by Directors: Bonney's $116.7K Bet on ALNY
August 30, 2016
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company...
Tags
Stocks
From
Market News Video
Grifols Barcelona Enters Oversold Territory (GRFS)
August 29, 2016
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
RSI Alert: Bio-Techne (TECH) Now Oversold
August 24, 2016
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
Top Buys by Top Brass: President & C.E.O. Capone's $212.4K Bet on MYGN
August 19, 2016
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider...
Tags
Stocks
From
Market News Video
Snag This Bargain Even Cheaper Than President Myriad RBM, Inc. McDade Did
August 17, 2016
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 12, Myriad Genetics, Inc.'s President Myriad RBM,...
Tags
Stocks
From
Market News Video
Another Endorsement for Biotech ETFs
August 16, 2016
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, and rival biotechnology exchange traded funds, seem to have put the woes experienced earlier this year...
Tags
Equities
FBT
REGN
From
ETF Trends
Large Cap Biopharmaceutical Metrics: Valuation Models For Future Growth
August 13, 2016
We reviewed large cap biotech stocks on July 3 just after the BREXIT bottom but prior to Q2 earnings and on May 8 after Q1 earnings. Here is data that offer comparisons of the core large cap holdings...
Tags
Healthcare
ETF's
Stocks / Equities
From
Blogs - TalkMarkets
Investors Land ACAD 6.0% Cheaper Than Its Secondary Stock Offering
August 11, 2016
Looking back to 2 days ago, Acadia Pharmaceuticals Inc (ACAD) priced a 6,060,606 share secondary stock offering at $33.00 per share. Buyers in that offering made a considerable investment into the...
Tags
Stocks
From
Market News Video
Wednesday's ETF Movers: GDX, FBT
August 10, 2016
In trading on Wednesday, the Gold Miners ETF (GDX) is outperforming other ETFs, up about 2% on the day. Components of that ETF showing particular strength include shares of Tahoe Resources (TAHO), up...
Tags
ETFs
From
ETF Channel
Surprising Analyst 12-Month Target For FBT
August 08, 2016
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Alkermes (ALKS) Shares Cross Above 200 DMA
July 25, 2016
In trading on Monday, shares of Alkermes plc (ALKS) crossed above their 200 day moving average of $50.15, changing hands as high as $50.31 per share. Alkermes plc shares are currently trading up about...
Tags
Stocks
From
Market News Video
Bullish Two Hundred Day Moving Average Cross - FBT
July 21, 2016
In trading on Thursday, shares of the First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) crossed above their 200 day moving average of $95.72, changing hands as high as $96.60 per share. First...
Tags
ETFs
From
ETF Channel
Analysts Forecast 27% Upside For FBT
July 15, 2016
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Biotech ETFs: Will the Once Hot Group Rebound?
July 13, 2016
The struggling biotechnology group and exchange traded funds such as the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, are leaving investors wondering...
Tags
equities
XBI
IBB
From
ETF Trends
Large Cap Biopharmaceuticals-Valuation Models 2016
July 03, 2016
The biotech sector has underperformed the market because of the severe correction in August/September of 2015 followed by another downdraft in January 2016 all the result of “bubble” valuations.
Tags
Healthcare
ETF's
Pharma/Biotech
From
Blogs - TalkMarkets
JUNO Crosses Below Key Moving Average Level
June 21, 2016
In trading on Tuesday, shares of Juno Therapeutics Inc (JUNO) crossed below their 200 day moving average of $41.95, changing hands as low as $41.82 per share. Juno Therapeutics Inc shares are currently...
Tags
Stocks
From
Market News Video
Expect More Election Year Volatility For Biotech ETFs
June 21, 2016
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs have disappointed investors for close to a year. Unfortunately, election...
Tags
featured
FBT
XBI
From
ETF Trends
Neurocrine Biosciences Breaks Below 200-Day Moving Average - Notable for NBIX
June 14, 2016
In trading on Tuesday, shares of Neurocrine Biosciences, Inc. (NBIX) crossed below their 200 day moving average of $45.94, changing hands as low as $45.72 per share..
Tags
Stocks
From
Market News Video
FBT's Underlying Holdings Could Mean 28% Gain Potential
June 13, 2016
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Oversold Conditions For Myriad Genetics (MYGN)
June 10, 2016
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
A Catalyst for Biotech ETFs
June 06, 2016
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, is up 9.2% over the past month. Performances for some rival biotech ETFs have been even better and...
Tags
IBB
XBI
equities
From
ETF Trends
Trying to Believe in Biotech ETFs
June 03, 2016
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs are vexing investors this year. Just when turnarounds for these funds look...
Tags
IBB
XBI
equities
From
ETF Trends
AGIO Crosses Above Key Moving Average Level
June 02, 2016
In trading on Thursday, shares of Agios Pharmaceuticals Inc (AGIO) crossed above their 200 day moving average of $58.79, changing hands as high as $60.20 per share. Agios Pharmaceuticals Inc shares are...
Tags
Stocks
From
Market News Video
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.